Position in JNJ
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$10,320,324
+$3,726,311 QoQ
Shares Held
40,636
+50.6% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
2.29%
of 13F equity value
Holder Rank
#1,093
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Archford Capital Strategies, LLC holds $29,267,302 across 10 Drug Manufacturers - General names. JNJ ranks #1 (35.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
40,636 | $10,320,324 | |
| 2 | NVS |
Novartis AG
|
49,908 | $7,821,581 | |
| 3 | MRK |
Merck & Co., Inc.
|
27,354 | $3,514,989 | |
| 4 | LLY |
ELI LILLY & Co
|
2,586 | $3,101,726 | |
| 5 | ABBV |
AbbVie Inc.
|
6,013 | $1,513,111 | |
| 6 | SNY |
Sanofi
|
33,227 | $1,417,463 | |
| 7 | AZN |
Astrazeneca PLC
|
2,652 | $502,872 | |
| 8 | PFE |
Pfizer Inc
|
18,376 | $442,494 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,320,324 | 40,636 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $6,594,013 | 26,976 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $5,178,509 | 25,023 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $2,498,534 | 13,475 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $1,396,746 | 9,144 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $1,520,918 | 9,171 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $1,329,057 | 9,190 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $1,480,580 | 9,136 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $1,393,781 | 9,536 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $2,063,904 | 13,047 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $2,128,842 | 13,582 | Shares | Sole | 2024-01-12 | |
| 2023-09-30 | $2,219,749 | 14,252 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $2,161,194 | 13,057 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $1,831,325 | 11,815 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $1,789,287 | 10,129 | Shares | Sole | 2023-01-26 | |
| 2022-09-30 | $1,627,719 | 9,964 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $1,727,349 | 9,731 | Shares | Sole | 2022-07-12 | |
| 2022-03-31 | $1,713,282 | 9,667 | Shares | Sole | 2022-04-18 | |
| 2021-12-31 | $1,522,180 | 8,898 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $1,349,171 | 8,354 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $1,351,691 | 8,205 | Shares | Sole | 2021-07-23 | |
| 2021-03-31 | $1,429,187 | 8,696 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $3,469,442 | 22,045 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $3,266,576 | 21,941 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $2,720,909 | 19,348 | Shares | Sole | 2020-07-24 | |
| 2020-03-31 | $2,540,906 | 19,377 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||